Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient | JACC: Case Reports
AL - Amyloidosis Foundation
Cureus | The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Garcia‐Pavia - 2021 - European Journal of Heart Failure -
Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis – Consult QD
Laboratory Testing in AL Amyloidosis | Download Scientific Diagram
Hemato | Free Full-Text | Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
Diagnosis and Management of the Cardiac Amyloidoses | Circulation
Diagnostics | Free Full-Text | Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
Journal of Lancaster General Health - Journal of Lancaster General Hospital
Full article: Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Garcia‐Pavia - 2021 - European Journal of Heart Failure -
Cureus | Slip-Ups in the Diagnosis of Cardiac Amyloidosis: A Case Fatality in Point
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine